Tennessee Oncology
In research, Tennessee Oncology stands highest in Medicine (#4,537 of 10,443 worldwide) and Health Sciences (#5,652 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 20.6× its share of world research.
- World rank, 2022–2025
- #9,542 of 28,054 · #10,978 all time
- Rank in United States
- #1,279 of 4,192
- Research works
- 601 ▲ 42% vs 2013–17
- Citations
- 21k 34.9 per fractional work
- Top-10% rate
- 21.0% record average 16.5%
- Open access
- 30% world 28%
What is Tennessee Oncology known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,537 of 10,443 | 23.0% | 96 | #3020 | |
| Health SciencesDomain | #5,652 of 11,982 | 22.8% | 101 | #4065 |
Each strip is that field’s whole ranked pool, with the notch where Tennessee Oncology sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Tennessee Oncology specialise in?
Where its research is concentrated relative to its size: Oncology takes 20.6× the share of its output that it takes of world research.
- OncologySubfield · 34.2 works21×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.4×. Every wedge is a field page.
- Immunology and Microbiology 3.4×
- Medicine 3.4×
- Economics, Econometrics and Finance 3.2×
- Biochemistry, Genetics and Molecular Biology 3.1×
- Dentistry 1.2×
- Health Professions 0.9×
- Nursing 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Neuroscience 0.3×
- Physics and Astronomy 0.3×
- Business, Management and Accounting 0.3×
- Chemistry 0.3×
- Decision Sciences 0.1×
- Mathematics 0.1×
- Materials Science 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Tennessee Oncology?
Ranked on the composite score, Davey B. Daniel, J. R. Infante and Todd M. Bauer lead among researchers whose main affiliation is Tennessee Oncology.
- 1 Davey B. Daniel United States · #85,697 worldwide 312 citations · 27 works
- 2 J. R. Infante United States · #213,837 worldwide 98 citations · 27 works
- 3 Todd M. Bauer United States · #781,984 worldwide 141 citations · 82 works
Which keywords describe research at Tennessee Oncology?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Targeted Therapy, Clinical Trials, Breast Cancer, Prognostic Factors, Tumor Microenvironment and Lymphoma.
- Trastuzumab
- Monoclonal Antibody
- Cancer Genomics
- Immune Checkpoint Blockade
- Metastatic
- Cell Cycle Control
- PET Imaging
- Biomarkers
- Chimeric Antigen Receptor
- Leukemia
- Cost of Care
- Metastasis
- ALK Inhibitors
- Genomic Profiling
- Tumor Regression
- Cancer Immunotherapy
- Lymphoma
- Prognostic Factors
- Clinical Trials
- Immunotherapy
- Chemotherapy
- Targeted Therapy
- Breast Cancer
- Tumor Microenvironment
- Quality of Life
- Metastatic Breast Cancer
- Radiotherapy
- Treatment Guidelines
- EGFR Mutations
- Precision Medicine
- Financial Toxicity
- CAR T Cells
- Rituximab
- Genomic Instability
- Cancer Therapy
- CDK4/6 Inhibitors
- Palbociclib
- PD-1 and PD-L1
- Mutational Signatures
- EGFR
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy19▲ 18×22 topics
- Immunotherapy16▲ 16×15 topics
- Targeted Therapy16▲ 48×5 topics
- Clinical Trials13▲ 13×10 topics
- Breast Cancer12▲ 34×11 topics
- Prognostic Factors11▲ 17×12 topics
- Tumor Microenvironment9▲ 14×8 topics
- Lymphoma9▲ 36×3 topics
- Quality of Life8▲ 3.7×11 topics
- Cancer Immunotherapy8▲ 34×3 topics
- Metastatic Breast Cancer8▲ 92×2 topics
- Tumor Regression7▲ 45×2 topics
- Radiotherapy7▲ 13×10 topics
- Genomic Profiling7▲ 45×2 topics
- Treatment Guidelines6▲ 20×2 topics
- ALK Inhibitors6▲ 70×1 topic
- EGFR Mutations6▲ 70×1 topic
- Metastasis6▲ 13×10 topics
- Precision Medicine6▲ 9.3×6 topics
- Cost of Care6▲ 136×1 topic
- Financial Toxicity6▲ 136×1 topic
- Leukemia6▲ 48×2 topics
- CAR T Cells6▲ 55×1 topic
- Chimeric Antigen Receptor6▲ 55×1 topic
- Rituximab6▲ 26×2 topics
- Biomarkers5▲ 5.2×7 topics
- Genomic Instability5▲ 33×3 topics
- PET Imaging5▲ 21×4 topics
- Cancer Therapy5▲ 6.2×14 topics
- Cell Cycle Control5▲ 116×2 topics
- CDK4/6 Inhibitors5▲ 138×1 topic
- Metastatic5▲ 55×2 topics
- Palbociclib5▲ 138×1 topic
- Immune Checkpoint Blockade5▲ 30×1 topic
- PD-1 and PD-L15▲ 30×1 topic
- Cancer Genomics5▲ 44×1 topic
- Mutational Signatures5▲ 44×1 topic
- Monoclonal Antibody5▲ 59×2 topics
- EGFR4▲ 97×1 topic
- Trastuzumab4▲ 61×2 topics
Which research topics does Tennessee Oncology publish most on?
By volume in 2022–2025: Lung Cancer Treatments and Mutations, Economic and Financial Impacts of Cancer, CAR-T cell therapy research and Advanced Breast Cancer Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works
- 2 Economic and Financial Impacts of Cancer Economics and Econometrics 6 works
- 3 CAR-T cell therapy research Oncology 6 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 5 works
- 5 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 6 Cancer Genomics and Diagnostics Cancer Research 5 works
- 7 HER2/EGFR in Cancer Research Oncology 4 works
- 8 Lung Cancer Research Studies Oncology 4 works
- 9 Chronic Lymphocytic Leukemia Research Genetics 3 works
- 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tennessee Oncology's research output changed?
Output in 2018–2022 was 42% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Nashville
- Vanderbilt University
- Vanderbilt University Medical Center
- Tennessee State University
- Meharry Medical College
- Vanderbilt Health
- Nashville Oncology Associates
- Hypertension Institute
- Belmont University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.